FDA.reportPublic FDA data

Micronized isotretinoin 8 MG Oral Capsule [Absorica]

RxCUI
2262731
RxNorm name
Micronized isotretinoin 8 MG Oral Capsule [Absorica]
Display name
Micronized isotretinoin 8 MG Oral Capsule [Absorica]
Full name
Micronized isotretinoin 8 MG Oral Capsule [Absorica]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:55

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Absorica LDISOTRETINOINSun Pharmaceutical Industries, Inc.3ef0cff8-19c1-4441-b780-fca6c7ee16152026-08-19Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2262731

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3ef0cff8-19c1-4441-b780-fca6c7ee1615Absorica LD 8 MG Oral Capsule [PSN] · Micronized isotretinoin 8 MG Oral Capsule [Absorica] [SBD] · Absorica LD 8 MG Oral Capsule [SY] · Micronized Absorica 8 MG Oral Capsule [SY]418These highlights do not include all the information needed to use ABSORICA/ABSORICA LD safely and effectively. See full prescribing information for ABSORICA/ABSORICA LD. ABSORICA ® (isotretinoin) capsules, for oral use ABSORICA LD ® (isotretinoin) capsules, for oral use Initial U.S. Approval: 198220230612